Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-11

Clinical Trial Update: Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adaptive chemotherapy for advanced breast cancer is currently recruiting. The sponsor is Sun Yat-sen University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Neoplasms | Phase 3 | Status: RECRUITING